ORBIMED ADVISORS LLC

CIK 000105595116 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001055951

Recent Transactions

50 trades

Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-10-01$10.34/sh−400→ 27,842 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-10-01$10.34/sh−400→ 27,842 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-10-01$10.34/sh−47,100→ 2,904,660 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-10-01$10.34/sh−47,100→ 2,904,660 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-30$10.17/sh−43,471→ 2,951,760 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-30$10.17/sh−369→ 28,242 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-30$10.17/sh−43,471→ 2,951,760 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-30$10.17/sh−369→ 28,242 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-29$10.08/sh−89→ 28,611 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-29$10.08/sh−10,469→ 2,995,231 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-29$10.08/sh−10,469→ 2,995,231 total
Sale
PROJECT SAGE OLDCO, INC.
Common Stock, par value $0.01 per share
2015-09-29$10.08/sh−89→ 28,611 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-07-01$20.04/sh−5,000→ 1,167,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-07-01$20.04/sh−5,000→ 1,167,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-07-01$20.04/sh−5,000→ 1,167,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-30$21.11/sh−4,717→ 1,172,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-30$20.33/sh−9,283→ 1,176,717 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-30$21.11/sh−4,717→ 1,172,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-30$20.33/sh−9,283→ 1,176,717 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-30$20.33/sh−9,283→ 1,176,717 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-30$21.11/sh−4,717→ 1,172,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-27$23.09/sh−9,212→ 1,186,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-27$21.79/sh−79,120→ 1,195,212 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-27$23.09/sh−9,212→ 1,186,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-27$21.79/sh−79,120→ 1,195,212 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-27$23.09/sh−9,212→ 1,186,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-06-27$21.79/sh−79,120→ 1,195,212 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2013-01-25$0.65/sh+1,762,000→ 1,762,000 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2013-01-25$0.65/sh+1,762,000→ 1,762,000 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2013-01-25$0.65/sh+1,762,000→ 1,762,000 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2013-01-25$0.65/sh+1,762,000→ 1,762,000 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2012-07-27$14.61/sh−362,844→ 825,756 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2012-07-27$14.61/sh−3,456→ 7,944 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2012-07-27$14.61/sh−362,844→ 825,756 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2012-07-27$14.61/sh−3,456→ 7,944 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2011-04-20$15.79/sh−7,600→ 25,700 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2011-04-20$15.79/sh−792,400→ 2,674,300 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2011-04-20$15.79/sh−7,600→ 25,700 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2011-04-20$15.79/sh−792,400→ 2,674,300 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2010-09-30$4.08/sh+19,900→ 3,449,734 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2010-09-30$4.08/sh+19,900→ 3,449,734 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2010-09-30$4.08/sh+19,900→ 3,449,734 total
Purchase
NxStage Medical, Inc.
Common Stock
2008-08-26$3.50/sh+27,700→ 5,718,256 total
Purchase
NxStage Medical, Inc.
Common Stock
2008-08-26$3.50/sh+27,700→ 5,718,256 total
Award
NxStage Medical, Inc.
Director's Stock Option (right to buy)
2008-07-23+11,667→ 11,667 total
Award
NxStage Medical, Inc.
Director's Stock Option (right to buy)
2008-07-23+11,667→ 11,667 total
Purchase
NxStage Medical, Inc.
Warrant (right to buy)
2008-05-23+1,111,111→ 1,111,111 total
Purchase
NxStage Medical, Inc.
Warrant (right to buy)
2008-05-23+1,111,111→ 1,111,111 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total

Companies

Recent Filings

Address

601 LEXINGTON AVENUE, 54TH FLOOR

NEW YORK, NY, 10022

View on SEC.gov